Mira Pharmaceuticals (MIRA) P/E (2023 - 2026)
Mira Pharmaceuticals (MIRA) P/E from Aug 3, 2023 to Jun 3, 2026. The TTM Mira Pharmaceuticals (MIRA) P/E is -3.51. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Mira Pharmaceuticals (MIRA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.51 | -14.84% |
| 2025 | -4.13 | +116.84% |
| 2024 | -1.90 | -2.06% |
| 2023 | -1.94 | N/A |
Comparison Mira Pharmaceuticals (MIRA) P/E with competitors
Mira Pharmaceuticals (MIRA) P/E is -3.51.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 10.39 | -395.64% |
| GRFS | Grifols SA | 11.29 | -421.18% |
| GSK | GSK Plc | 12.14 | -445.35% |
| PFE | Pfizer Inc | 12.31 | -450.18% |
| SNY | Sanofi | 12.33 | -450.92% |
| BMY | Bristol-Myers Squibb Company | 13.54 | -485.39% |
| OGN | Organon & Company | 14.21 | -504.35% |
| BIIB | Biogen Inc | 17.38 | -594.59% |
| GILD | Gilead Sciences Inc | 18.01 | -612.56% |
| JNJ | Johnson & Johnson | 20.68 | -688.53% |
| NVS | Novartis AG | 21.64 | -715.84% |
| AMGN | AMGEN Inc | 23.21 | -760.53% |
| MRK | Merck & Co Inc | 27.45 | -881.09% |
| AZN | Astrazeneca plc | 27.89 | -893.69% |
| LLY | Lilly(Eli) & Company | 45.43 | -1392.63% |
| ABBV | Abbvie Inc | 122.69 | -3591.09% |